It is worth noting that even though individuals with typical diabetes or lipid abnormalities often exhibit significant reductions in adiponectin and elevations in leptin, early compensatory mechanisms may happen in generally healthy individuals or animal models. This evidence concerns the gene ADIPOQ and diabetes mellitus.